Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and papa nonoate

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with papa nonoate in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(papa nonoate)		Trials
(papa nonoate)		Recent Studies (post-2010) (papa nonoate)
9,1561875525608

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumgartner, W; Kuebler, WM; Reppien, E; Samapati, R; Solymosi, EA; Uhlig, S; Yang, Y; Yin, J1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and papa nonoate

ArticleYear
Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase.
    The European respiratory journal, 2010, Volume: 36, Issue:2

    Topics: Animals; Capillary Permeability; Caveolin 1; Dexamethasone; Hydrazines; Lung; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Platelet Activating Factor; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Sphingomyelin Phosphodiesterase; Steroids

2010